Me CEO Anne Wojcicki continues to maintain a strong outlook despite recent high-profile stumbles. “We are a long-term company ...

Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq. So what ...

With a massive divorce settlement from Google’s Sergey Brin, the former Democrat is remaking herself as a pro-Trump ‘Make America Healthy Again’ wellness guru.

In this podcast, Motley Fool analyst Jason Moser and host Mary Long discuss the semiconductor supply chain, ASML's earnings, ...

The entire board of DNA testing company 23andMe resigned after a conflict with CEO Anne Wojcicki over her plan to take the ...

With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to ...

A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?

Over the past year, 23andMe set new corporate governance lows. CEO Anne Wojcicki now enters de facto “founder mode” after a ...

Ambience Healthcare - the leading clinical AI platform for scribing, point-of-care CDI, patient summaries, and referrals - today announced that it has received a 97.7%* Spotlight Report score from ...

Turmoil at 23andMe, and a lawsuit alleging that GEDmatch shares data with Facebook, highlights how far your genetic ...

Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...

Financial and security chaos at the once-pioneering genetic testing firm has intensified concerns about user data. Here's how ...